- HCR5001 Public Health Report on STIs: NCSP Model Extract
- HSC CM1 Equality, Diversity and Rights in Health and Social Care: Task 1 Sample Answer
- Proposed Practice Change Presentation: Falls-Risk Assessment in Community Nursing (Level 6 Sample)
- MOD011086 Population Healthcare and Health Improvement Assignment Sample 2026 | ARU
- Nurs1591 Leading Complex Care for Women, Newborn Infants and Families Assignment Sample 2026
- K323 Investigating Health And Social Care Assignment Sample UK
- K316 Exploring practice Assignment Sample UK
- K240 Mental Health And Community Assignment Answers UK
- MD7123 Clinical Research Methods & Biostatistics Assignment Sample UK
- MD7001 Evidence-Based Medicine Assignment Sample UK
- XN7064 Sociology And Psychology And Public Health Assignment Sample UK
- MQF Level 3 Award In Health Care Assignment Answer UK
- Role of Communication in Health and Social Care Essay Sample
- Safeguarding the Vulnerable Adults from Abuse Essay Sample
- Working Partnership in Health & Social Care Essay Sample
- Safeguarding in Health and Social Care Essay Sample
VTCT UBT501 LO1 Topical Anaesthetics: Model Answer Extract
For information and reference only – not to be submitted as your own work. This extract shows how a Level 4 answer on topical anaesthetic regulation can be structured; your own submission must reflect your own research, your centre’s guidance and your assessor’s instructions.
This sample is a model-answer extract for VTCT Skills Level 4, unit UBT501 (Principles, practices and ethical considerations for advanced aesthetic therapies), Learning Outcome 1, written as a short answer response (SAR) for Assignment Paper B, Task 1. It follows the shape of the real task: analyse the regulatory landscape and professional standards for topical anaesthetic products, then evaluate your findings. A short note at the end explains how to structure the companion Task 2 answer on advanced skin assessment (UBT503, LO3).
The answer below runs to roughly 1,000 words, which is the length a learner who asked for a fuller Task 1 response would typically aim for. Tables are used where the task asks you to compare, because markers can then see your reasoning quickly. For a step-by-step method, read our guide to answering VTCT UBT501 Assignment B Task 1. The live brief page is not yet published, so the closest hub is the UK questions archive.
Task 1 model answer: regulation and professional standards for topical anaesthetic products (UBT501 LO1)
Introduction
Topical anaesthetics reduce discomfort during needle-based and energy-based aesthetic treatments, but they are medicines, so their use is governed by medicines law as well as by sector standards. This answer analyses the UK regulatory landscape and professional standards that apply to these products, describes current dispensing models, compares voluntary and mandatory regulatory bodies, and evaluates the importance of clinical oversight. Each finding is judged against patient safety, accountability and practicability for a therapist working in a clinic.
Legal status of topical anaesthetic products
The Human Medicines Regulations 2012 control how medicines are sold and supplied in the UK. A prescription-only medicine (POM) may be sold or supplied only in accordance with a prescription from an appropriate practitioner, such as a doctor, dentist, or a nurse or pharmacist independent prescriber (Human Medicines Regulations 2012, reg. 214). A medicinal product that is not on the general sale list may be sold only from a registered pharmacy by, or under the supervision of, a pharmacist (reg. 220).
Local authority guidance drawing on JCCP advice explains that licensed topical products at around 5% active ingredient or less are normally supplied as pharmacy (P) medicines, whereas stronger products are normally prescription-only (Lancaster City Council, n.d.). The practical consequence is clear: a therapist cannot buy numbing cream in bulk and hand it to clients on their own authority. The exact category of any named product should always be confirmed from its licence information.
Current dispensing models
| Model | How it works | Strengths | Limitations |
|---|---|---|---|
| Client buys a P medicine from a registered pharmacy | The pharmacist advises the client, who applies the product before the appointment as instructed. | Lawful route that needs no prescriber; pharmacist counselling. | Therapist has little control over timing, quantity or application site. |
| Prescriber-led, patient-specific supply | An independent prescriber assesses the client and issues a prescription or patient-specific direction for a named person. | Matches the product to individual need; clear accountability. | Needs a working relationship with a prescriber and a face-to-face assessment. |
| Stock held in the clinic | The clinic keeps products for general use. | Convenient for the practitioner. | Generally not acceptable without a prescription or pharmacy supply for a named individual; the JCCP regards stocking prescription medicines for this purpose as contrary to medicines legislation (JCCP, 2021). |
| Remote prescribing | A prescriber issues medication without examining the client in person. | Fast and cheap. | Not endorsed by the JCCP, which reports that the GMC and GPhC would not accept it for cosmetic treatments, except where delay could cause harm (JCCP, 2021). |
Taken together, the first two models are defensible. The last two shift risk from the provider to the client and weaken the audit trail.
Voluntary and mandatory regulatory bodies
| Body | Status | Role relevant to topical anaesthetics | Limitation |
|---|---|---|---|
| MHRA | Mandatory (statutory) | Enforces medicines law; receives Yellow Card adverse-event reports and reports of unlawful supply (Lancaster City Council, n.d.). | Cannot routinely inspect every clinic. |
| GMC, NMC, GPhC | Mandatory for their registrants | Set prescribing and conduct standards, for example the GMC guidance on prescribing and managing medicines in effect from 5 April 2021 (GMC, 2021). | Apply only to registered professionals, not to every aesthetic practitioner. |
| Local authorities | Mandatory where a local scheme applies | Register or licence premises for special treatments in some areas (DHSC, 2025). | Requirements vary by area. |
| Healthcare Improvement Scotland | Mandatory in Scotland | Independent clinics must be registered with it (Healthcare Improvement Scotland, n.d.). | Scotland only; no regulatory requirement yet for non-healthcare providers. |
| Wales special procedures licensing | Mandatory in Wales | Licences for acupuncture, body piercing, electrolysis and tattooing, including micro pigmentation (Public Health (Wales) Act 2017). | Does not list injectable or topical aesthetic treatments. |
| JCCP and CPSA | Voluntary | Register practitioners and set training and competency standards and prescribing positions (House of Commons Library, 2025; JCCP, 2021). | No legal power to compel compliance. |
| Save Face | Voluntary | Register of inspected practitioners, accredited by the Professional Standards Authority (Professional Standards Authority, n.d.). | Open to limited professions; membership is by choice. |
In England, section 180 of the Health and Care Act 2022 gives the Secretary of State power to require personal and premises licences for certain cosmetic procedures (Health and Care Act 2022, s. 180). The government’s response of 7 August 2025 confirmed a three-tier model (green, amber and red by risk), with local authorities administering green and amber and the CQC overseeing red (DHSC, 2025). Sources checked for this answer recorded no commencement date, so a learner should confirm the current position on GOV.UK before submission.
Buy Non Plagiarized & Properly Structured Assignment Solution
Importance and impact of clinical oversight
Clinical oversight matters because topical anaesthetics carry real risks: allergic reaction, excessive absorption over large areas, and masking of early warning signs during a procedure. A prescriber who has examined the client can judge skin condition, allergy history and medication, set a quantity and monitor the outcome. The JCCP requires a physical and psychological examination before prescribing aesthetic medicines and states that, where treatment is delegated, the client remains under the prescriber’s care (JCCP, 2021).
The government has also said it will explore oversight requirements for procedures that need a POM, and it noted concern about face-to-face consultation and about nurse independent prescribers being unable to hold stock (DHSC, 2025). The impact on practice is a more documented pathway: consultation, patient record, named supply, clear escalation if a reaction occurs.
Evaluation of findings
The strongest finding is that the law is clear about supply but fragmented about practitioners. Medicines law applies to everyone, yet professional regulators cover only registered staff, and the voluntary registers rely on goodwill. A therapist without prescribing rights is therefore safest using the client-purchase or prescriber-led routes and recording both.
The main weakness of the current system is uneven enforcement and a licensing scheme that is not yet operating. Voluntary bodies raise standards but cannot compel them. Until licensing arrives, the most reliable safeguard is the therapist’s own discipline: working within scope, refusing informal supply and seeking prescriber oversight. On balance, the evidence supports treating clinical oversight as a minimum expectation rather than a best-practice extra.
How to structure Task 2 (UBT503 LO3 advanced skin assessment)
Task 2 is a separate answer of about 800 words and should not borrow content from Task 1. Plan it as five short, labelled sections that mirror the prompts in the brief, and keep every section applied to a realistic client rather than generic.
| Section | What to cover | Word guide |
|---|---|---|
| Preparing self and work area | Protocols for hygiene, PPE, equipment, consent paperwork and environment. | 120 |
| Consultation techniques | Questioning, medical and lifestyle history, expectations, communication style. | 170 |
| Advanced skin analysis | Methods and technology used to assess skin and what each reveals. | 170 |
| Limiting factors | Contraindications, medications, skin condition and client circumstances. | 170 |
| Treatment planning | Linking findings to a justified plan, review points and aftercare. | 170 |
You can compare this layout with our pages on VTCT assignment help and beauty therapy assignment help, or see how a different awarding body frames a similar topic in the Qualifi Level 5 CO503 aesthetic practice example. More worked examples sit in the healthcare answers category.
About the expert
Reviewed by the Students Assignment Help academic team. Meet the writers on our experts page.
Please Write Fresh Non Plagiarized Assignment on this Topic
References
Department of Health and Social Care (2025) The licensing of non-surgical cosmetic procedures in England: consultation response. Published 7 August 2025. Available at: https://www.gov.uk/government/consultations/licensing-of-non-surgical-cosmetic-procedures/outcome/the-licensing-of-non-surgical-cosmetic-procedures-in-england-consultation-response (Accessed: 20 October 2026).
General Medical Council (2021) Good practice in proposing, prescribing, providing and managing medicines and devices. Available at: https://www.gmc-uk.org/ethical-guidance/ethical-guidance-for-doctors/good-practice-in-prescribing-and-managing-medicines-and-devices (Accessed: 20 October 2026).
Healthcare Improvement Scotland (n.d.) Healthcare Improvement Scotland issues warning about the dangers of Botox parties. Available at: https://www.healthcareimprovementscotland.scot/publications/healthcare-improvement-scotland-issues-warning-about-the-dangers-of-botox-parties/ (Accessed: 20 October 2026).
Health and Care Act 2022, c. 31, s. 180. Available at: https://www.legislation.gov.uk/ukpga/2022/31/section/180 (Accessed: 20 October 2026).
House of Commons Library (2025) The regulation of non-surgical cosmetic procedures in England. Research Briefing CBP-10331, by B. Balogun. Available at: https://commonslibrary.parliament.uk/research-briefings/cbp-10331/ (Accessed: 20 October 2026).
Human Medicines Regulations 2012, SI 2012/1916, regs. 214 and 220. Available at: https://www.legislation.gov.uk/uksi/2012/1916/regulation/214/made (Accessed: 20 October 2026).
Joint Council for Cosmetic Practitioners (2021) JCCP reaffirms its position on safe prescribing in the aesthetics sector. Press Release 47, 1 November 2021. Available at: https://www.jccp.org.uk/ckfinder/userfiles/files/JCCP%20Reaffirms%20its%20position%20on%20safe%20prescribing%20in%20the%20aesthetics%20sector.pdf (Accessed: 20 October 2026).
Lancaster City Council (n.d.) The use and supply of topical anaesthetics. Available at: https://www.lancaster.gov.uk/assets/attach/13885/The-use-and-supply-of-topical-anaesthetics.pdf (Accessed: 20 October 2026).
Professional Standards Authority (n.d.) Save Face: accredited register. Available at: https://www.professionalstandards.org.uk/find-a-register/detail/save-face (Accessed: 20 October 2026).
Public Health (Wales) Act 2017, anaw 2, Part 4. Available at: https://www.legislation.gov.uk/anaw/2017/2/notes/division/4/4 (Accessed: 20 October 2026).
UPTO 35% DISCOUNT
